Literature DB >> 22526962

Further considerations on adverse reactions to radiopharmaceuticals.

Massimo Salvatori, Giorgio Treglia, Nadia Mores.   

Abstract

Mesh：

Year:  2012        PMID： 22526962     DOI： 10.1007/s00259-012-2120-1

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  10 in total

1.  European system for reporting adverse reactions to and defects in radiopharmaceuticals: annual report 2000.

Authors:  S E Hesslewood
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-04-12       Impact factor: 9.236

2.  Adverse events in nuclear medicine - cause for concern?

Authors:  B Hesse; N Vinberg; A K Berthelsen; J R Ballinger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-05       Impact factor: 9.236

3.  [The 27th Report on Survey of the Adverse Reaction to Radiopharmaceuticals (the 30th survey in 2004)].

Authors:  Kiyoko Kusakabe; Terue Okamura; Kanji Kasagi; Akio Komatani; Yukimitsu Sato; Hiroshi Matsuda; Hirotaka Maruno
Journal:  Kaku Igaku       Date:  2006-02

4.  [The 28th report on survey of the adverse reaction to radiopharmaceuticals (the 31st survey in 2005)].

Authors:  Kiyoko Kusakabe; Yasushi Arano; Terue Okamura; Kanji Kasagi; Akio Komatani; Hiroshi Matsuda; Hirotaka Maruno
Journal:  Kaku Igaku       Date:  2007-02

5.  [The 30th report on survey of the adverse reaction to radiopharmaceuticals (the 33rd survey in 2007)].

Authors:  Hiroshi Matsuda; Yasushi Arano; Hidehiko Okazawa; Terue Okamura; Sunao Mizumura; Kunihiko Yokoyama
Journal:  Kaku Igaku       Date:  2009-03

6.  Prevalence of adverse reactions to positron emitting radiopharmaceuticals in nuclear medicine. Pharmacopeia Committee of the Society of Nuclear Medicine.

Authors:  E B Silberstein
Journal:  J Nucl Med       Date:  1998-12       Impact factor: 10.057

Review 7.  Pitfalls with radiopharmaceuticals.

Authors:  Ralph Santos-Oliveira; Márcio Machado
Journal:  Am J Med Sci       Date:  2011-07       Impact factor: 2.378

8.  [The 29th report on survey of the adverse reaction to radiopharmaceuticals (the 32nd survey in 2006)].

Authors:  Kiyoko Kusakabe; Yasushi Arano; Terue Okamura; Kanji Kasagi; Akio Komatani; Hiroshi Matsuda; Hirotaka Maruno
Journal:  Kaku Igaku       Date:  2008-02

9.  Frequency of adverse reactions to radiopharmaceuticals in Europe.

Authors:  S R Hesslewood; D H Keeling
Journal:  Eur J Nucl Med       Date:  1997-09

10.  Prevalence of adverse reactions in nuclear medicine. Pharmacopeia Committee of the Society of Nuclear Medicine.

Authors:  E B Silberstein; J Ryan
Journal:  J Nucl Med       Date:  1996-01       Impact factor: 10.057
  10 in total
  2 in total

1.  American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy.

Authors:  Shannon M Bates; Anita Rajasekhar; Saskia Middeldorp; Claire McLintock; Marc A Rodger; Andra H James; Sara R Vazquez; Ian A Greer; John J Riva; Meha Bhatt; Nicole Schwab; Danielle Barrett; Andrea LaHaye; Bram Rochwerg
Journal:  Blood Adv       Date:  2018-11-27

2.  Analysis of Unusual Adverse Effects After Radium-223 Dichloride Administration.

Authors:  Viviana Frantellizzi; Mariano Pontico; Arianna Pani; Roberto Pani; Giuseppe De Vincentis
Journal:  Curr Radiopharm       Date:  2020
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.